These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16689094)

  • 21. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A; Henzgen M; Rajakulasingam K
    Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens.
    Quercia O; Bruno ME; Compalati E; Falagiani P; Mistrello G; Stefanini GF
    Eur Ann Allergy Clin Immunol; 2011 Dec; 43(6):176-83. PubMed ID: 22360134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of specific immunotherapy in children with seasonal allergic rhinitis and conjunctivitis, sensitized to grass pollen].
    Bulawa E; Borysewicz G; Markiewicz K; Derentowicz P
    Med Wieku Rozwoj; 2001; 5(4):351-8. PubMed ID: 12004142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific immunotherapy in pollinosis: II. Forecasting changes in certain cytoimmunological indicators after four years of immunotherapy in pollinosis.
    Zieliński AE
    J Investig Allergol Clin Immunol; 1996; 6(6):364-70. PubMed ID: 9015780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Wüthrich B; Häfner G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pollen allergy and immunotherapy].
    Schmid-Grendelmeier P
    Ther Umsch; 2012 Apr; 69(4):239-48. PubMed ID: 22477663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
    Niggemann B; Jacobsen L; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Koller D; Norberg LA; Urbanek R; Valovirta E; Wahn U; Möller C;
    Allergy; 2006 Jul; 61(7):855-9. PubMed ID: 16792584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pollionosis: I. Findings on the clinical aspects and the pollen spectrum in 1565 pollen-sensitive patients].
    Wüthrich B; Annen H
    Schweiz Med Wochenschr; 1979 Sep; 109(33):1212-8. PubMed ID: 493910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
    Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
    J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchial inflammation in seasonal allergic rhinitis with or without asthma in relation to natural exposure to pollen allergens.
    Panzner P; Malkusová I; Vachová M; Liška M; Brodská P; Růžičková O; Malý M
    Allergol Immunopathol (Madr); 2015; 43(1):3-9. PubMed ID: 24075536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allergen-specific immunotherapy in the treatment of pollen allergy].
    Mailhol C; Didier A
    Rev Mal Respir; 2013 Feb; 30(2):142-51. PubMed ID: 23419445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyposensitization treatment of allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial.
    Astarita C; Scala G; Sproviero S; Franzese A
    J Investig Allergol Clin Immunol; 1996; 6(4):248-55. PubMed ID: 8844502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 36. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.
    Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.